Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.350
-0.340-4.42%
Volume:144.26M
Turnover:1.07B
Market Cap:84.69B
PE:18.29
High:7.710
Open:7.640
Low:7.340
Close:7.690
52wk High:11.454
52wk Low:4.152
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.69
T/O Rate:1.25%
Dividend:0.25
Dividend Rate:3.34%
EPS(LYR):0.402
ROE:10.83%
ROA:5.65%
PB:2.34
PE(LYR):18.29
PS:2.99

Loading ...

BRIEF-CSPC Pharmaceutical Says Pan Weidong Resigns As Executive Director

Reuters
·
Yesterday

CSPC (1093) Announces Updated Board Composition and Committee Assignments

Bulletin Express
·
Yesterday

CSPC Pharmaceutical Group Files Director List with HKEX

Reuters
·
Yesterday

CSPC Pharmaceutical Group Appoints Dr. Li Chunlei as Authorised Representative

Reuters
·
Yesterday

CSPC PHARMA (01093): Dr. Li Chunlei Appointed as Authorized Representative

Stock News
·
Yesterday

CSPC Pharmaceutical - Pan Weidong Resigns as Executive Director

THOMSON REUTERS
·
Yesterday

Madrigal Pharma Q3 revenue rises on Rezdiffra demand

Reuters
·
Yesterday

CSPC PHARMA Executive Director Fined RMB5 Million by CSRC, Retains Right to Appeal

Deep News
·
Yesterday

CSPC Pharmaceutical Group Stock Slips 4.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Yesterday

CSPC (01093) Announces Unchanged Issued Shares in October 2025

Bulletin Express
·
Nov 03

Executive Director Fined 5 Million Yuan for Insider Trading, CSPC PHARMA Assures Normal Operations

Deep News
·
Nov 03

BRIEF-Cspc Pharmaceutical Says Executive Director Received "Decision On Administrative Penalty"

Reuters
·
Nov 03

CSPC Innovation Suspends Trading Amid Proposed Acquisition and Fundraising

Reuters
·
Nov 03

CSPC Pharmaceutical - Executive Director Received "Decision on Administrative Penalty" Issued by Csrc

THOMSON REUTERS
·
Nov 03

CSPC Pharmaceutical - Csrc Ordered Exec Director to Deal With Illegally Held Securities in Accordance With Law, and Imposed Fine of RMB5 Mln

THOMSON REUTERS
·
Nov 03

Did CSPC’s siRNA and ADC Regulatory Wins Just Shift Its (SEHK:1093) Investment Narrative?

Simply Wall St.
·
Nov 03

Assessing CSPC Pharmaceutical Group (SEHK:1093) Valuation After Latest Regulatory Milestones and R&D Pipeline Advances

Simply Wall St.
·
Nov 01

CSPC Pharmaceutical Group Stock Rises 2.4% in Hong Kong

Dow Jones
·
Oct 31

CSPC Pharmaceutical Group Stock Sheds 2.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Oct 30

HK Stock Connect Shareholding Changes as of October 30

Stock News
·
Oct 30